-+ 0.00%
-+ 0.00%
-+ 0.00%

Alphamab Oncology Appoints David Ng as Chief Financial Officer

PUBT·11/12/2026 00:04:03
Alphamab Oncology Appoints David Ng as Chief Financial Officer
  • Alphamab Oncology appointed David Ng chief financial officer in an announcement dated November 12, 2026.
  • Outgoing CFO Fei Wang resigned due to other work commitments.
  • Ng previously headed investor relations and capital strategies at HUTCHMED, following a CFO role at MEDx Translational Medicine Research (Suzhou).
  • His responsibilities will cover capital markets strategy, investor relations and industry competitive analysis.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261112-12409120), on November 12, 2026, and is solely responsible for the information contained therein.